Aims: This paper is an elaborate and quantitative attempt to construct medically applicable mathematical models and derive criteria for efficacious Highly Active Anti-Retroviral Therapy (HAART) protocol for an AIDS patient. The patho-physiological dynamics of Human Immuno-deficiency Virus type 1 (HIV-1) induced AIDS during HAART is modeled by a system of non-linear deterministic differential equations. The physiologically relevant and clinically plausible equations depict the dynamics of uninfected CD4 + T cells (x 1 ), HIV-1 infected CD4 + T cells (x 2 ), HIV-1 virions in the blood plasma (x 3 ), HIV-1 specific CD8 + T cells (x 4 ), and the concentration of HAART drug molecules (x 5 ). The major objective of this research is to construct an elaborate mathematical model that depicts patho-physiodynamics of HIV-1 virions during HAART. The derived therapeutic criteria are expressed in terms of clinically measurable physiological parameters. Investigative computer simulations which describe certain aspects of HIV-1 dynamics during HAART are also presented in the paper. Study Design: The mathematical model is constructed based on contemporary research data condensed from the clinical literature on HAART of AIDS. A system of coupled non-linear deterministic differential equations are used to characterize the patho-physiodynamics of BJMCS, 5(2): 262-299, 2015; Article no.BJMCS.2015.018 263 HAART during the post chronic phase. The mathematical analysis of the model equations and the computer simulations are performed with regard to HAART protocols with constant continuous intravenous and transdermal drug infusions. A syncytium term with stoichiometric coefficient is introduced into the model to account for the formation of large multinucleated gp120 bearing CD4 + T cells that are observed in some AIDS patients. By assigning a zero value to the stoichiometric coefficient, the role of syncytium is abrogated. Place and Duration of Study: This research was done at Fayetteville State University, North Carolina USA, and is sponsored by the FSU Mini-Grant Award and the HBCU Graduate STEM Grant. The research was conducted during the Spring of 2012. Methodology: The deterministic nonlinear dynamics of HIV-1 AIDS equations are analyzed using the techniques of dynamical system theory, principles of linearized stability, non-linear system theory, and other relevant mathematical techniques. The clinically desirable equilibrium states, their local existence, and global stability are analyzed. Investigative computer simulations are performed illustrating some physiological outcomes.
Introduction
Highly Active Anti-retroviral Therapy (HAART) is currently the most therapeutically efficacious treatment protocol for treating the Acquired Immunodeficiency Syndrome (AIDS). HIV-1 virions induce AIDS by orchestrating an irreversible destruction of the CD4 + T cells which then paralyze the immune system of the HIV-1 positive person. The major objectives of HAART therapy are the prolongation and improvement of the long-term life quality of patients; optimization of therapy such as to suppress the HIV-1 viral load to below 50 copies of HIV-1 RNA; reconstitution of the patients' immune system such that the CD4 + T cells proliferate to carrying capacity; and minimization of drug toxicity. HAART treatment protocol consists of nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, antifungals /anti-bacterials and in future, integrase inhibitors. The reverse transcriptase inhibitors prevent reverse transcription of HIV-1 specific DNA. The protease inhibitors are antagonistic to maturation and formation of new HIV-1 virions. The possible role of integrase inhibitors is to prevent the integration of HIV-1 viral DNA into the patients' DNA [1, 2] .
In order to achieve the therapeutic goals of HAART, it is plausible to involve the techniques of mathematical modeling. Before the advent of HAART, the primary focus of the mathematical modelers is to quantitatively analyze the observed patho-physiodynamics of HIV-1 infection in the AIDS patients. These earlier research papers involve the pioneering work of Perelson et al. [3] , Nowark et al. [4] , and other contributors [5, 6] .
A recent paper by Nani and Jin [7] provided some physiological criteria under which HIV-1 virions in an AIDS patient can be annihilated during HAART.
Some of the earlier mathematical modeling publications focus on single-drug AIDS therapy using Zidovudine (INN) or Azidothymidine (AZT) [8] . Then the advent of Active Retro-viral Therapy (ART) and the associated clinical limitation let to the development of HAART treatment protocols. In spite of the initial success of HAART, there are clinically measurable and observable shortcomings in the treatment of AIDS [9] . In particular, HAART is not successful in about 40% of AIDS patients because of drug-induced toxicity and complications of treatment. HAART protocols have been clinically observed to have limited therapeutic efficacy due to biochemical/clinical drug resistance, short drug half-life, low bio-availability and blood plasma toxicities.
Mathematical modeling provides a quantitative and rational approach to solve the therapeutic efficacy problems associated with HAART. In particular, the models focused on finding optimal therapeutic schedules, the roles of latent viral reservoirs as well as minimizing of toxic side effect [5, 6, 8, [10] [11] [12] [13] [14] .
Mathematical models which incorporate the explicit computation of the cure rate of HIV-1 induced AIDS during HAART include models by [15] [16] [17] .
During HAART, the major obstacle to total viral eradication is the existence of viral reservoirs and retroviral latency [18] . Retroviral latency is defined as an integrated pro-virus with no active transcription. This is associated with low-level chronic viral and persistent cryptic HIV-1 replication. These processes lead to viral persistence after initial successful HAART [18] . Mathematical models which demonstrate persistence due to viral reservoirs have been constructed by Nani and Jin [15, 16] . Other models which elegantly address the role of viral reservoirs in persistence include papers by Rong and Perelson in [19] , Kim and Perelson in [20] , and Sedaghat, Siliciano and Wilke in [21] .
Optimal therapies that will minimize side effects have been investigated by many authors in [3] [4] [5] 7, 8, 14, 22, 23] . Zaric et al. in 1998 [24] presented a model which was focused on the simulation of protease inhibitors and role of drug resistant HIV-1 virions. Stengel in [22] presented a mathematical model of HIV-1 infection and HAART which demonstrated the efficacy of a mathematically optimal therapy. Caetano and Yoneyama in [11] constructed a HAART model which incorporated the roles of latently infected CD4 + T cells, and discussed how the reverse transcriptase and protease inhibitors affected HIV-1 dynamics during HAART, using the LQR, Scheme. In particular, Hattaf and Yousfi incorporated the basic reproductive number R 0 in determination of optimal HIV therapy in [25] . In a separate paper, the same authors constructed a delayed differential equation model of HIV-1 dynamics during therapy in [26] . They employed a numerical algorithm and Pontryagin's Maximum Principle in determination of the optimal therapies. In a future paper, we will use Pontryagin's Minimal Principle to construct admissible optimal therapies such as to minimize the toxicity of the drug but maximize the therapeutic efficacy of HAART.
In this paper, an elaborate mathematical model will be constructed which will incorporate physiologically plausible effects such as Michaelis-Menten kinetics, role of HIV-1 latent viral reservoirs, continuous transdermal drug delivery, and the implicit lymphocyte proliferation induction by the CD4 + T cells. The activation and proliferation is accomplished by a paracrine and autocrine processes which are mediated by the cytokine interleukin-2, secreted by the CD4 + T cells. A special feature of the current paper is the inclusion of the syncytium production term to the HIV-1 virion compartment. It has been shown by Koot et al. [27] in that syncytium inducing HIV-1 variants, occurring 2 years before progression to AIDS, on an average, significantly increase the rate of CD4+ declines. The destruction mechanism of CD4+ and CD8+ T cells due to syncytium formation and other mechanisms has been described by Shut et al. [28] . These features are incorporated in the current paper by assigning two separate cell loss rates. The HIV virions can also disintegrate by releasing the soluble HIV-1 envelope protein gp120 into the blood plasma which can attach to uninfected CD4+ T cells, causing attack by antibodies thereby increasing the rate of decline of immuno-competent CD4+ T cells. Mathematical structures are used in the current model to demonstrate these aspects of HIV-1 and CD4+ T cell dynamics.
Several authors investigated the consequences of structured long-term and short-term treatment interruptions during HAART [9] [10] [11] 14 ]. The current model will discuss these consequences by means of simulations.
The current paper will be divided into eight sections. The first section gives the introduction into HAART therapy and provides the basis for current research. This is followed by presentation and discussion of the model parameters in Section 2. In Section 3 the mathematical model of HAART therapy will be constructed. Also the necessary and sufficient criteria for annihilation of HIV-1 virions during HAART will be presented in sections 4, 5, and 6. In Section 7, clinically plausible computer simulations will be exhibited. Section 8 will conclude the paper.
Parameters
In this section, the physiological variable and parameters of the HAART model equations will be defined and explained. It must be emphasized that some of these parameters are biologically measurable or can be estimated using clinical techniques. In clinical experience, these parameters are different from patient to patient depending on their patho-physiological conditions. A list of model parameters, constants, and variables is shown as follows. All the parameters are positive.
Model Equations

Description of the Model Equations
The HIV-1 patho-physiological dynamics during HAART therapy can be modeled using the following system of non-linear ordinary differential equations. A detailed description of the dynamics of the model variables x 1 , x 2 , x 3 , and x 4 can be found in Nani and Jin [15] .
The model includes the following clinical improvements:
(i) The drug delivery uses transdermal, stealth-liposome encapsulated drug delivery, instead of the matrix tablet form because of improved therapeutic efficacy and reduced gastrointestinal toxicity [12] . It is also assumed that elastic liposomes are formulated and selectively targeted such as to reduce toxicity to non-HIV-1-infected CD4 + T cells (x 1 ) and CD8 + cytotoxic T cells (x 4 ). (ii) The HAART drug is such that each renal excretion and body clearance rate follows Michaelis-Menten kinetics. 
Boundedness and Invariance of Non-negativity of Solutions
In this subsection theoretical conditions will be constructed under which solutions to the HAART mathematical model equations are well-posed, ultimately bounded, and exhibit invariance of nonnegativity for all
. In this case, t 0 , and T are defined respectively as times at which HAART therapy begins and terminates. (1, 2, 3, 4, 5) } are ultimately bounded, dissipative, and will eventually enter the non-negatively invariant region Ω. In particular, the solutions are trapped in the region Ω for all
Proof. Using the result from Nani and Jin in [7] , let In particular, the following results can be obtained. Thus, Ω is non-negatively invariant and the system is ultimately bounded, dissipative, with the bounds defined by the following equations.
As a consequence of (3.7), the orbits of x i (t) are uniformly bounded.
This completes the proof.
The Equilibria and Computation of the Jacobian Matrices
In this section, the model equations will be restricted to the case for which the drug input function has the form f(t) = 1. Thus, (3.1) reduces to a system (4.1) of deterministic, non-linear, and autonomous ordinary differential equations. 
Local Existence Criteria for Clinically Relevant Steady States of HAART
In this subsection, a subset of clinically relevant states or the possible patho-physiological outcomes from constant continuous transdermal HAART therapy are listed and analyzed. These outcomes are labelled E i for i = 1, 2, …, 10. The local existence criteria are labelled C i . This equilibrium also corresponds to a scenario of successful HAART protocol in which the steady state consists of some uninfected CD4+ T cells and some drug residue but no HIV-1 specific CD8+ T cells.
This equilibrium exhibits a failure of HAART protocol. In particular, the HIV-1 infected CD4+ T cells and HIV-1 virions populate the steady state in addition to some drug residue whereas the non-infected CD4+ and CD8+ T cells are annihilated. This equilibrium is not clinically desirable because of existence of HIV-1 infected CD4+ T cells.
This equilibrium is another scenario of therapeutic failure of HAART protocol because HIV-1 infected CD4+ T cells are all present.
The steady state E 10 depicts a person who is living with AIDS. In this case, the model exhibits persistence and the viral titer is not sufficient to annihilate the immune system. The criteria for persistence of HIV-1 AIDS during HAART will be discussed in Theorem 5.5.
There are some other steady states which are not listed because they are less clinically interesting.
Computation of the Jacobian Matrices
Using the Hartman-Grobman theorem, it is possible to investigate the therapeutic efficacy of HAART and the physiological stability of HIV-1 AIDS disease dynamics associated with the model equations, by linearizing the system (4.1) in the neighborhood of the equilibria.
The Jacobian matrix of linearization near any physiological outcome is denoted symbolically by In particular, the a ij entries are defined as follows:
The Jacobian matrices for the steady states E 3 , E 4 , E 5 are respectively listed as follows: 4  3  2  2  2   2  5  3   3  3  3  3  1  5  3   5  3  3  3  3  2  2  3  2  3  3   2  5  2   2  2  2  2  2  1  1  5  2   5  2  2  2  2  2  2  2   3  1  1  2  1   5  3  2 5  3  3  3  4  1   1  3  3  2  2   2  5  2   2  2  2  2  2  1  1  1  2  5  2   5  2  2  4  1  2  1  2  1  2  2  2  1  2  2  2   1  1  1  1 
Necessary Criteria for Local Stability of Equilibria during HAART
Let E = {E 1 , E 2 , …,E 10 } denote the set of some clinically relevant equilibria of model equations (4.1). In this section, the local stability of E 4 , E 5 , E 1 , and E 3 will be analyzed using the principles of linearized stability of autonomous ordinary differential equations. In particular, the necessary mathematical criteria for certain therapeutic outcomes during HAART are computed and presented in the form of theorems. The eigen-spectrum is therefore given by .2) guarantee that the eigen-values associated with the equilibrium E4 have negative real part by virtue of Routh-Hurwicz criteria [7] . Hence, the equilibrium is locally asymptotically stable and a local attractor as well as a hyperbolic sink. This theorem establishes the local existence and local stability of a clinically desirable physiological outcome of HAART protocol.
Local Stability of
Clinical Implication 5.1. The criteria (5.1) and (5.2) guarantee a temporary cure for the AIDS patient. There will be a finite time interval during which the HIV-1 virions will be annihilated from the patient's blood plasma. This will however be short-lived because the rest point E 4 [x 1 , 0,0, 0, x 5 ] may become unstable and the criteria for temporal cure are violated. It is possible for therapeutic criteria to be derived to maintain the patient to be permanently free of AIDS, which we shall discuss in Theorem 5.5. + T cells. Consequently, the immune system of the AIDS patient becomes incapacitated and the patient becomes the target of opportunistic infections. However, this situation may not last very long but could be fatal.
] , 0 , , , 0 [ 5 3 2 5 x x x E ( ( ( = In this subsection, the local existence and stability of ] , 0 , , , 0 [ 5 3 2 5 x x x E ( ( ( = will be analyzed. The results are summarized in the following theorem.
In this subsection, the local existence and local stability of the non-clinically efficacious equilibrium E 1 will be discussed. Then the equilibrium E 1 is hyperbolic sink, locally asymptotically stable, and a local attractor if given by (4.3). Then the corresponding eigen-spectrum is given by the equation: + T cells are all decimated. This is not a therapeutically desirable clinical outcome, because the patient may become severely incapacitated. To avoid this scenario, the HAART therapy must implemented in such a way that criterion (5.9) is violated. 
Persistence Analysis of HAART
The pathophysiology of HIV-1 persistence during HAART is described elaborately in the paper by Pomerantz in [18] . In this subsection, the mathematical criteria for viral persistence during HAART will be derived. The interior rest point E 10 exists if and only if the system (4.1) exhibits persistence. This describes a situation in which the patient survives for a long time with AIDS. It is possible during HAART that, the HIV-1 virions cannot be annihilated but instead the system persists in a chronic configuration in which the blood plasma levels of the HIV-1 virions co-exist with the other clinically measurable parameters such as uninfected CD4 + T cells, the HIV-1 infected CD4 + T cells, HIV-1 specific CD8 + T cells, and HAART drug molecules. The criteria for existence of E 10 are listed in the following theorem. 
Proof. For a proof refer to Nani and Jin [7, 15, 16] .
Clinical Implication 5.5. If uninfected CD4 + T cells, infected CD4
+ T cells, the HIV-1 viral mRNA copies in the blood plasma, HIV-1 specific cytotoxic CD8 + T cells, and the HAART drug concentration are within certain thresholds, then the AIDS patient will live with AIDS. If any of the conditions listed in (5.11) are violated, the patient will experience unpredictable therapeutic outcomes including full-blown AIDS or spontaneous elimination of HIV-1 virions.
Sufficient Criteria for Permanent Cure of AIDS during HAART
In this section, the sufficient criteria for permanent annihilation of HIV-1 virions during HAART will be derived. The clinically desirable physiological outcomes are E 4 [x 1 , 0,0, 0, x 5 ] and E 3 = [x 1 , 0, 0, x 4 , x 5 ]. It must be recalled that E 4 corresponds to the physiological outcome in which HIV-1 infected CD4 + T cells, the HIV-1 virions in the blood plasma and HIV-1 specific CD8 + T cells are eliminated in the blood plasma of the AIDS patient. The sufficient criteria for E 4 will be discussed first. The global asymptotic stability of E 4 in Ω will be established respect to the flow emanating from Clinical Implication 6.1
Global Stability of
is a measure of the rate at which the CD4 + T cells (x 1 ) are activated by interleukin-2 (IL-2) in an autocrine process when the physiological flow during HAART tends to E 4 . It is possible to attach a biochemical measure to coefficient a 1 and
. This can be done as follows: 
Global Stability Analysis for
is analyzed. The aim is to find the sufficient criteria under which the HIV-1 virions in the blood plasma, the HIV-1 infected CD4 + T cells are annihilated but the HIV-1 specific CD8 + T cells will persist as memory T cells as well as the CD4 + T cells and some drug residues will remain in the AIDS patient. It is expected that the CD4 + T cells will eventually repopulate to their carrying capacity whereas the drug residues will ultimately dissipate. The analysis will be similar to the preceding one for E 4 . The derivative of V along the solution curves of the model equations yields the result: (6.22) But it can be shown that (6.23) In particular, (cf. Nani and Jin [7, 15, 16] ) (6.24) Similarly, (6.25) Using the specifications in (4.31), the matrix C has the form (6.26) The matrix C is negative definite if the following criteria hold: . Consider the patho-physiological equilibrium
x ] is globally asymptotically stable with respect to the flow emanating
In particular E 3 is a global attractor. Consequently, all the HIV-1 virions will be permanently annihilated in the AIDS patient.
Proof. The patho-physiological equilibrium E 3 is a global attractor if
is negative definite, or equivalently if the matrix C is negative definite. ButC is negative definite if conditions (6.27) (i), (ii), (iii) hold (cf. Gantmacher [30] ). Note that (6.27) 
, then c 12 = 0, which leads to the fulfillment of (6.27) (ii). But c 33 < 0 and c 12 = 0 whereas c 11 c 22 > 0. Thus condition (6.27) (iii) is satisfied. As a result, * V is negative definite. Therefore, E 3 becomes a global attractor and hence the theorem follows.
Clinical Implications 6.2
(i) Theorem 6.2 gives the sufficient theoretical criteria for the HIV-1 infected CD4 + T cells and HIV-1 virions in the blood plasma to be eradicated during HAART. This theorem also provides the conditions under which HIV-1 specific CD8
+ T cells will persist as memory cells after the HAART therapy.
(ii) It is possible to express the conditions of Theorem 6.2 in terms of clinically measurable biophysical parameters. By using Taylor expansions of and , the condition is approximately equivalent to the expression (6.28) This can be interpreted to mean that HAART will cure the AIDS patient if the number density of uninfected CD4 + T cells is equal to the Michaelis-Menten constant of the IL-2 activation of the CD8 + T cells, which in turn has to be less than twice Michaelis-Menten constant of the IL-2 activation of the CD4 + T cells. Proof. The conditions (6.27)(i),(ii), (iii) hold if the theorem hypothesis is satisfied. This makes the matrix C in (6.19) negative definite. Consequently, the equilibrium becomes global attractor. 
Simulations and Discussion of Results
Investigative computer simulations will be presented and discussed. These simulations are performed using clinically plausible hypothetical patient patho-physiological parametric configurations. In particular, the simulations executed for the non-autonomous version of the model equations as displayed in (7.1).
The drug input function f(t) is a technical construct such as to generate the rectangle pulse function as shown in Section 3.1. It represents a periodically calibrated transdermal or intravenous or caplet drug matrix input with period ω. In particular,
f(t) = f(t+ω)
where ω=6.25 days It should be noted that the system (4.1) represents HAART during constant continuous caplet drug matrix input which is different from the scenarios used in the simulations of this section.
The complete mathematical analysis of the non-autonomous system (7.1) using Floquet Theory and Theory of non-linear periodic Dynamical Systems will be done in a future publication.
The numerical estimates used are variations of estimates published in the references: [3, 4, 11, 19, 20, 23] . Some techniques for estimating HIV-I dynamical parameters includeMonte Carlo simulation and polynomial regression analysis. The investigative computer simulations elucidate several dynamical aspects of HIV-1 AIDS dynamics which are based on the respective parametric configurations. The x-axis of the simulation graphs is calibrated in months.
Simulation Results for Hypothetical AIDS patient #1
The AIDS patho-physiological parametric configuration of hypothetical patient #1 is denoted by P 1 and exhibited in Table 1 . The simulation results show that the HAART protocol impairs HIV-1 
Simulation Results for Hypothetical AIDS patient #2
The hypothetical AIDS patient #2 is assigned the patho-physiological parametric configuration P 2 as presented in Table 2 . The simulation results are exhibited in Fig. 2 . It can be observed that this patient does have a clinically favorable prognosis under HAART treatment protocol. The AIDS patho -physiodynamics during the given HAART protocol is similar to that for patient #1, as the patient #2 also undergoes immune system reconstitution in which the CD4 + T cells repopulate. On the other hand, the proliferative activity of the HIV-1 specific CD8
+ T cells appears to be downregulated. 
Simulation Results for hypothetical AIDS patient #3
For this scenario, the patho-physiological parametric configuration of hypothetical patient #3 is as shown in Table 3 . It must be noted that HIV-1 AIDS dynamics during HAART treatment protocol in this patient is exacerbated by contributions from latent reservoirs in contrast to the other hypothetical patients. The results of the simulation are shown in Fig. 3 . This is a non-equilibrium AIDS configuration simulation as it is evident parametric configuration and by the simulation time profile. The simulation results show that during the given HAART protocol, the hypothetical AIDS patient #3 experiences annihilation of uninfected CD4 + T cells and the HIV-1 specific CD8 + T cells . Consequently, immune system paralysis occurs as a consequence of the low CD4 + Tcell number density, leading to an exponential increase of the blood plasma HIV-1 viremia. This simulation represents an unfavorable AIDS outcome during HAART. 
Simulation Results for Hypothetical AIDS Patient #4
In this scenario, the drug input is continuous for 6 months and off for another 6 months until HAART is discontinued. Fig. 4 presents an unsuccessful HAART therapy for a hypothetical AIDS patient with the patho-physiological parametric configuration P 4 in Table 4 . In this HAART scenario, the plasma HIV-1 virions (x 3 ) completely overwhelmed the non-infected CD4 + T helper cells (x 1 ) and the HIV-1 specific CD8 + cytotoxic T cells (x 4 ). The HIV-1 infected CD4 + T cells (x 2 ) exhibit periodic dynamics and the prognosis for the hypothetical patient is unwholesome (see Nani and Jin [15, 16] ). 
Conclusion
The current paper is elaborate and quantitative attempt to construct medically applicable mathematic models and derive criteria for efficacious HAART protocol for an AIDS patient. The mathematical equations presented in Section 3 are a generalization of the models by Perelson et al. [3] , Wodarz and Nowak [5] , and Tan et al. [23] , and many other authors by incorporating more clinically relevant parameters of HIV-1 patho-physiodynamics. In particular, interleukim-2 activation of both CD4 + T cells and CD8 + T cells are implicitly incorporated into the model. In this paper, it has been demonstrated that the parameters (a 1 , b 1 ) and (a 4 , b 4 ) play a significant role in determining the efficacious outcomes of HAART. Clearly, the clinically desirable outcomes are the rest points E 4 and E 3 . The criteria for the existence of E 4 and E 3 are listed respectively in Theorem 5.1, and Theorem 5.4.These theorems give the conditions under which both E 4 and E 3 can be temporarily or transiently attained. The criteria for E 4 and E 3 to become global attractors are listed in Theorem 6.1 and Theorem 6.2. These theorems, expressed in terms of simple clinically attainable and measurable parameters, give the sufficient conditions for the cure of AIDS. It will be emphasized that there exist other therapeutic criteria but these are intractable and extremely arduous to achieve in a clinical setting.
One essential feature of this research is that the HAART protocol is implemented by using the constant continuous intravenous infusion or constant continuous transdermal infusion of the drug. As such, the criteria derived in this paper are applies to these settings. The mathematical model for intermittent caplet or matrix tablet per oral drug administration can be derived using the nonautonomous version of the model equations involving the drug input function f(t) discussed by Nani and Jin in [7] .
The scenarios for clinical failure during HAART due to extreme drug toxicity are represented by the rest points E 1 and E 5 .The criteria for these therapeutic outcomes are described by Theorem 5.3 and Theorem 5.2, respectively.
In conclusion, it must be emphasized that these theoretical results do not constitute clinical cures unless the results are implemented together with other pharmacological protocols for the AIDS patients. There may exist other theoretical results which are not explicitly discussed in this publication. Nevertheless it is essential to note that mathematical modeling has a place in the quest for the treatment and cure for HIV-1 induced AIDS. Using the techniques of the mathematical modeling and non-linear system analysis, we demonstrated that the activation and kinetic rate constants as well as the rates of influx from latently infected reservoir are important factors in the determination of the prognosis and therapeutic efficacy of HAART.
The future work will involve the construction of mathematical models which will describe an AIDS therapy using HAART in addition to ACI (Active Cellular Immunotherapy) involving interleukim-2. Also, in the future, the mathematical model for HAART will include the roles of mutations such as the delta32 CCR5 on therapeutic outcomes.
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